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Abstract 
Marker-free transgenic crops confer several advantages over transgenic 
crops equipped with e.g. genes coding for antibiotic resistance. Firstly, the European 
Union encourages notifiers for introductions of GMOs in the environment to “avoid 
or minimize the inclusion of superfluous transgenes or sequences” and it promotes 
the use of clean vector systems. Secondly, the number of selection genes allowing the 
preferential growth of transformed cells and tissues is limited and often a gene 
transfer protocol for a specific crop or even a cultivar depends on the use of one 
specific selectable marker gene. Hence, stacking of genes within the same transgenic 
line is difficult once a selectable marker gene has been introduced. If these marker 
genes can be removed, the subsequent introduction of the next gene-of-interest is 
greatly facilitated. At Plant Research International a system has been developed for 
specific elimination of any introduced DNA/gene sequences using site-specific 
recombination combined with selection for successful removal using a negative 
selection system. Completely marker-free transgenic plants have been obtained 
using a model vector, both in an efficient transformation system (strawberry) as well 
as in a non-efficient transformation system (apple). Frequencies were more than 
adequate. Presently. A versatile vector set providing a choice of several selectable 
markers and carrying a multiple cloning site for receiving cassettes of the gene-of-
interest is available for application in, amongst others, ornamental crops. 
 
BACKGROUND 
Genetically modified (GM) food products are looked upon with a certain degree of 
mistrust by the majority of European consumers. Almost 50 % of the consumers think 
that GM food is less safe for human consumption than non-GM food products. 33 % is 
not sure. Only 20 % of the consumers know that there is no scientific basis to these 
doubts on food safety. While on the one hand players in the food production chain, such 
as breeding companies, growers/farmers and biotechnology firms, are convinced of the 
technical and economic benefits, the consumers on the other hand perceive risks to human 
health, to the environment and to biodiversity. In the USA and other countries around the 
globe, e.g. Argentina, Canada, China, and India, GM crops are more and more 
implemented in agriculture, however, the European input in research and development of 
GM crops has been reduced from 1998 on. This de-facto moratorium on the introduction 
of new GM crops has been in force since 1999. As a consequence of this, 51 % of the 
European Small and Medium Enterprises (SMEs) at present do not use genetic 
engineering approaches, but most of them indicated that there has been a change in their 
strategy in the last few years abandoning GM related R&D projects. 
Recently in July 2003, the ban on import of GM food products has been lifted by 
the European Union (EU) with the proviso, that all products containing more than 0.9 % 
of EU-approved GM material have to be labelled. Also, the European Parliament has 
formulated guidelines based on their desire to provide the European consumers with a 
choice to either accept or avoid the consumption of any GM or GM-derived food 
products. For this, completely separated production and processing chains will have to be 
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set up. In practice, this might turn out to be too expensive for the industry presenting yet 
another barrier to the implementation of GM food in Europe. Another consequence of this 
EU policy is the negative impact it has on imports of food from the USA and the 
reluctance of developing countries to grow GM crops out of fear to reduce their export 
possibilities to the EU. 
In order to change the perception of the EU consumers it might not be advisable to 
force GM crops and food upon them by enforcing official WTO rules and by too much 
pressure by the USA. Instead, consumers should regain confidence and trust in their 
scientists and government organizations. This can only be achieved by communicating 
clearly the benefits of particular GM crops and by highlighting the relevance of these 
crops to the individual consumer. Consumers should be able to relate to the goals of the 
modification and to the way followed to achieve these goals. If applicable, it should be 
explained that alternatives do not really exist or are less beneficial than the GM approach. 
Next to this, technical solutions to some of the concerns that consumers expressed are 
sought by science and can be applied.  
In a ‘Guidance Document for the risk assessment of GM plants and derived food 
and feed’ by the Joint Working Group on Novel Foods and GMOs prepared for the EU 
recommendations encompass amongst others the encouragement of notifiers to develop 
GM crops in which only DNA essential to the desired modification is introduced, e.g. 
clean vector technology. Overall, three principle ways are identified: 
- avoid or minimize the inclusion of superfluous transgenes or sequences; 
- avoid or minimize superfluous expression of the transgene; 
- avoid or minimize the dispersal of transgenes in the environment. 
Plant Research International (PRI) has extended this view to all GM-crops 
including ornamentals and added to this list the preferential use of gene sequences or 
promoters which are species- or at least plant-derived. This combined with PRIs own 
clean vector system and transparent communication on PRI arguments why and when to 
use GM technology will hopefully contribute to a broader public acceptance of genetic 
modification of plants. 
 
CLEAN VECTOR TECHNOLOGY 
Clean vector technology aims to produce GM plants with only the gene-of-interest 
as newly introduced gene function, so without any superfluous gene sequences. Primarily, 
the goal is to avoid the use or the continued presence of antibiotic resistance genes as 
selectable markers. Four approaches to achieve this can be followed.  
A. No Selectable Marker  
Here, GM plants are produced by Agrobacterium inoculation followed by 
regeneration of shoots without the use of a selectable agent. This will lead to a (great) 
number of plants, the majority of which are non-transgenic. However, depending on 
the regeneration and gene transfer frequencies, some plantlets will be transgenic and 
they will have to be identified, e.g. by a dedicated PCR screening on DNA of several 
sets of pooled plants. A prerequisite is a regeneration/transformation protocol of high 
efficiency. So far, this method is limited to model species and a low number of 
specific crop cultivars, e.g. in potato.  
B. Cotransformation 
In this system the selectable marker gene is physically separated from the gene-of-
interest. This can be on different T-DNAs residing on the same or on separate binary 
vector(s). The separate binary vectors can be present in the same or in separate 
Agrobacterium strains. The two T-DNAs should become integrated in two 
genetically unlinked loci. After selection for the GM plants by growth on antibiotic 
or herbicide containing media subsequent segregation after sexual crossing of 
resistant regenerants should result in GM plants equipped only with the gene-of-
interest. A prerequisite here is that the crop can be sexually propagated without 
losing too many traits or cultivar identity and this within a reasonable time frame. For 
vegetatively propagated crops or crops with a very long sexual cycle, such as tulip or 
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apple, this approach is less feasible.  
C. Non-Antibiotic-Based Selection  
The most well known example in this respect is, of course, herbicide tolerance. 
However, also in this case there might be aspects linked to it that can be considered 
undesired by certain consumer groups. An alternative system that was developed 
recently is based on metabolic processes, more particularly on the carbohydrate 
metabolism. The phospho mannose isomerase (PMI) system is based on the fact that 
plant cells in tissue culture cannot metabolise mannose and therefore, cannot grow on 
medium with this compound as a sole source of carbon. By providing GM cells with 
a gene converting mannose into fructose this barrier is overcome and GM plantlets 
can be obtained. As a consequence, however, they then still carry this bacterium-
derived selectable marker gene at a stage where it is actually no longer needed, i.e. in 
crop cultivation.  
D. Excision by Recombination 
In this approach selectable marker genes or rather any unwanted (or no longer 
wanted) gene sequence, can be physically removed from the GM cells or regenerated 
GM plants. Necessary is a recombinase enzyme working on two specific 
recombination sites. All of this has to be introduced into the primary transformants, 
next to the gene-of-interest and the selectable marker gene. Placing everything, which 
has to be removed ultimately, between the recombination sites ensures that in the 
final GM plant product only the gene-of-interest remains. Control over the 
recombinase activity is essential. This can be achieved by regulating or inducing 
expression of the recombinase gene or by inducing recombinase enzyme activity. 
Problems related to this technique are leakiness of the recombinase regulation, 
effectiveness of the induction process and recovery of 100 % homogeneous 
recombined GM plants. Using a negative selection marker for transgenic, non-
recombined cells or plantlets can cover this last aspect. This means that the prolonged 
presence of the negative selection gene will lead to cell death or an easily identifiable 
aberrant phenotype. Only the desired marker-free plants survive or will look normal. 
 The induced expression of a recombinase gene (Cre) is reported by Zuo et al. 
(2001), where a promoter is used comprising a estrogen receptor-based transactivator. 
Ebinuma et al. (1997) used the ipt gene as a phenotypical negative selection marker, the 
presence of which results in an aberrant phenotype. At Plant Research International we 
use a synthetic copy of the recombinase ( R) gene of Zygosaccharomyces rouxii, which is 
fused to the ligand binding domain (LBD) of a corticosteroid receptor. The R gene is 
continuously expressed, but the protein is inactive due to the translational fusion to LBD. 
Activity can be re-established by treatment with dexamethason (DEX). A dual positive-
negative selectable marker consisting of a fusion between the nptII gene (positive) and the 
codA gene (negative) are also a part of the PRI system. The nptII gene provides the cell 
with the competence to grow on medium supplemented with e.g. the antibiotic 
kanamycin, i.e. positive selection. The cytosine deaminase (codA) gene product converts 
fluorocytosine (FC; non-toxic) into the toxic fluorouracil (FU), hence cells carrying this 
gene will die on medium with FC, i.e. negative selection. As stated earlier all of these 
elements are placed between the two Rs recombination sites.  
The steps required for the production of marker-free GM plants are: 
1) Inoculation of explants with Agrobacterium carrying the appropriate vectors as binary 
plasmids, according to established protocols. 
2) Selection of transgenic material by growth on antibiotic containing media, again 
according to existing protocols. 
3) Induction of recombinase activity by applying a DEX treatment. 
4) Selection for marker-free plantlets by applying regeneration protocols in the presence 
of FC as a negative selectable agent for non-successful recombination events. 
5) A thorough molecular characterization of the end products should confirm the 
transgenic and marker-free nature of the plants produced. 
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In Fig. 1 a model vector, pRCNG, is presented showing all the aforementioned 
elements. In addition it contains the GUS coding region without a promoter. One Rs site 
is present between the R gene and the 35S promoter driving its expression. Upon 
recombination the 35S promoter is combined with the gus gene leading to GUS positive 
staining as a confirmation of the recombination event. An copy of the hpt gene outside the 
Rs sites in this model vector allows further use of positive selection when required. 
The model construct has been successfully applied in potato, strawberry and apple 
(Schaart et al.). The first two represent efficient transformation systems and the latter 
being much more recalcitrant. So far, the system of recombinase activity inhibition and 
induction by DEX did not prove to be 100 % effective. However, combined with the 
existing protocols and tissue culture/regeneration expertise in the crops tested, it easily led 
to many homogeneous marker-free GM plants, indicating that 100 % effectiveness is not 
required.  
A ‘standard’ vector (Fig. 2) has been assembled with all and only the elements 
needed, now including promoter-driven R expression between the Rs sites and a multiple 
cloning site (MCS) outside them allowing introduction of any gene (expression) cassette 
leading to the trait of choice. At present, we are testing the efficiency of these new vectors 
based on the ‘standard’. In apple, a gene conferring scab resistance derived from barley 
was equipped with the rubisco promoter of Chrysanthemum for application in our marker-
free system; in strawberry a strawberry disease-resistance gene was combined with a 
strawberry tissue-specific promoter. For ornamental crops, new standard vectors are being 
made, e.g. containing the dual positive-negative selectable marker under control of the 
rubisco promoter of chrysanthemum for application in this crop. In another example the 
vector contains a dual positive-negative selectable marker based on a fusion between the 
hpt gene (hygromycin resistance, positive) and the codA gene (negative) for application 
within bulbous ornamental crops such as lily and gladiolus.  
This concurs with the Plant Research International strategy for the production of a 
new generation of GM crops: marker-free, containing preferably a combination of a plant 
(or species) derived promoter and a plant (or species) derived gene (see earlier). This, we 
sincerely hope, will lead to a broader acceptance of these crops by a majority of the 
public, although it is acknowledged that this approach represents merely a technical 
solution to some of the objections, and not an answer to every issue raised by consumers 
at the moment. 
Plant Research International is willing to enter into collaborations with interested 
parties to apply the system on specific crops of interest. 
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Fig. 1. The pRCNG modelvector 
 
 
 
 
Fig. 2. The standard MF-vector (MF=marker-free) 
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